Pulmonary infection in elderly cancer Treatment of Chinese and Western Medicine.doc

 PAGE \* MERGEFORMAT 9 Pulmonary infection in elderly cancer Treatment of Chinese and Western Medicine [Abstract] [Objective] To investigate cancer patients with pulmonary infection effective measures. [Method] 68 patients with malignant tumors in patients with pulmonary infection in patients with the use of antibiotics based on the combination of TCM syndrome differentiation. [Results] 41 patients with markedly effective in 22 cases; ineffective in 5 cases, total effective rate was 92.65%. [Conclusion] The combination of Chinese and Western medicine to treat malignant tumors in patients with pulmonary infection method has important applications. [Keywords:] cancer; lung infection; Differential Treatment In recent years, with the accelerated process of China’s aging, the elderly the incidence of malignant tumors are seeing a gradual upward trend. Because the elderly immune function is low, the organ decay, and most patients with multiple diseases, to accept a variety of more invasive operation, resulting in significantly increased risk of infection, while the most common site of infection to the lungs. This article in July 2005 -2,007 hospital in December after years of rule of elderly cancer patients with pulmonary infection in 68 cases clinical data were retrospectively analyzed to investigate the cancer patients with pulmonary infection in effective measures. A clinical data 1.1 General Information 68 cases of malignant tumors were our hospital patients, those who are oldest 96 years old, the smallest in 68 years, an average of 76.34 years of age. Male 47, female 21 cases. In which 35 cases of lung cancer; 8 cases of gastric malignancy; 19 cases of liver cancer; four cases of colorectal cancer; two cases of laryngeal cancer. 1.2 Research Methods 68 patients were admitted to hospital after a detailed medical records, including course records, diagnosis and treatment, hematology tests, imaging data, onset date, the site of infection, bone marrow hype